NASDAQ: VIRVir Biotechnology Inc Stock Ownership - Who owns Vir Biotechnology?
Insider buying vs selling
Have Vir Biotechnology Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Brent Sabatini | SVP Chief Accounting Officer | 2026-06-01 | 379 | $9.45 | $3.58kSell |
| Janet Napolitano | Director | 2026-06-01 | 3,200 | $9.45 | $30.24kSell |
| Vicki L. Sato | Director | 2026-05-01 | 22,000 | $10.05 | $221.03kSell |
| Backer Marianne De | President and CEO | 2026-04-06 | 72,559 | $9.16 | $664.35kSell |
| Vicki L. Sato | Director | 2026-04-01 | 22,000 | $9.07 | $199.61kSell |
| Brent Sabatini | SVP Chief Accounting Officer | 2026-03-23 | 7,711 | $9.12 | $70.32kSell |
| Vicki L. Sato | Director | 2026-03-02 | 200 | $9.98 | $2.00kSell |
| Vicki L. Sato | Director | 2026-03-02 | 21,800 | $9.50 | $207.19kSell |
| Mark Eisner | EVP and Chief Medical Officer | 2026-02-25 | 1,889 | $9.82 | $18.55kSell |
| Verneuil Vanina De | EVP General Counsel Corp Sec | 2026-02-25 | 13,700 | $9.82 | $134.53kSell |
VIR insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when VIR insiders and whales buy or sell their stock.
VIR Shareholders
What type of owners hold Vir Biotechnology Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Blackrock Inc | 10.67% | 17,998,329 | $164.86M | Institution |
| Alaska Permanent Fund Corp | 9.88% | 16,666,668 | $152.67M | Insider |
| Svf Endurance Cayman Ltd | 8.14% | 13,728,924 | $125.76M | Insider |
| Arch Venture Management LLC | 7.66% | 12,916,663 | $118.32M | Institution |
| Sb Investment Advisers Uk Ltd | 6.49% | 10,948,093 | $100.28M | Institution |
| Vanguard Portfolio Management LLC | 5.46% | 9,215,577 | $84.41M | Institution |
| Gsk PLC | 5.07% | 8,550,954 | $78.33M | Institution |
| State Street Corp | 4.23% | 7,141,094 | $65.41M | Institution |
| Temasek Holdings Private Ltd | 3.26% | 5,499,999 | $50.38M | Insider |
| Vanguard Capital Management LLC | 3.19% | 5,382,103 | $49.30M | Institution |
VIR vs Biotech Stocks
Vir Biotechnology Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.